M3 Medical expands into the UK endovenous market with leading global partners
M3 Medical, part of the Uniphar Medtech Group, recently announced that it has launched its endovenous portfolio into the UK market.
A press release notes...
VVT Med announces positive clinical data for ScleroSafe published
VVT Med has announced the publication of a peer-reviewed clinical study evaluating the short-term efficacy and safety of its ScleroSafe catheter-directed sclerotherapy system. The...
Invera Medical reports 12-month results from pilot trial of infusion device showing vein closure...
Invera Medical recently announced 12-month results from its pilot clinical study of the Invera infusion device, designed to treat chronic venous disease (CVD). The...
CX 2026: Venous and lymphatic session highlights continued innovation following recent PE trials
“Are we at the end of the road with this technology?” asked attendees of yesterday’s opening venous and lymphatic session at the 2026 Charing...
